Abits
ABTS
CleanSpark
CLSK
MicroStrategy
MSTR
FRMO CORP
FRMO
Ebang International
EBON
US Stock MarketDetailed Quotes
TERN Terns Pharmaceuticals
- 4.800
- -0.210-4.19%
Close Jan 13 16:00 ET
- 4.780
- -0.020-0.42%
Post 17:47 ET
407.71MMarket Cap-4.07P/E (TTM)
4.930High4.640Low1.68MVolume4.920Open5.010Pre Close7.97MTurnover2.89%Turnover RatioLossP/E (Static)84.94MShares11.40052wk High1.12P/B278.76MFloat Cap4.32052wk Low--Dividend TTM58.07MShs Float28.360Historical High--Div YieldTTM5.79%Amplitude1.450Historical Low4.756Avg Price1Lot Size
About Terns Pharmaceuticals Company
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-? agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.
Company Profile
SymbolTERN
Company NameTerns Pharmaceuticals
Listing DateFeb 5, 2021
Issue Price17.00
Founded2017
CEOMs. Amy Burroughs
MarketNASDAQ
Employees66
Fiscal Year Ends12-31
Address1065 East Hillsdale Boulevard,Suite 100
CityFoster City
ProvinceCalifornia
CountryUnited States of America
Zip Code94404
Phone1-650-525-5535
Websitehttp://www.ternspharma.com
Company Executives
- Name
- Position
- Salary
- Amy Burroughs
- Chief Executive Officer and Director
- --
- Melita Sun Jung
- Chief Business Officer
- --
- Elona Kogan
- Chief Legal Officer
- --
- Dr. Mark J. Vignola, PhD
- Principal Accounting Officer, Chief Financial Officer and Treasurer
- 3.14M
- Dr. Emil T. Kuriakose, M.D.
- President and Head, Research and Development
- --
- David Fellows
- Chairman of the Board
- 340.15K
- Dr. Erin Quirk, M.D.
- President and Head of Research and Development
- 4.67M
- Heather D. Turner
- Director
- --
- Dr. Radhika Tripuraneni, M.D.,M.P.H.
- Director
- 303.06K
- Dr. Carl L. Gordon, C.F.A.,PhD
- Independent Director
- 298.99K
- Jeffrey B. Kindler, Esq.
- Independent Director
- 304.99K
- Jill M. Quigley, Esq.
- Independent Director
- 306.14K
- Dr. Hongbo Lu, PhD
- Independent Director
- 299.99K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.